Charles River Laboratories (CRL) Tops Q2 EPS by 16c; Raises Outlook

Go back to Charles River Laboratories (CRL) Tops Q2 EPS by 16c; Raises Outlook

Charles River Labs (CRL) PT Raised to $120 at Barclays

August 9, 2018 4:52 AM EDT

Barclays raised its price target on Charles River Labs (NYSE: CRL) to $120.00 (from $110.00) while maintaining a Equalweight rating.

... More